Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rethinking the coagulation cascade.

Maureane M Hoffman1, Dougald M Monroe

  • 1Department of Pathology, Durham Veterans Affairs Medical Center, Durham, NC 27705, USA. maureane.hoffman@gte.net

Current Hematology Reports
|September 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms of thrombin inhibition by protein S and the TFPIα-fVshort-protein S complex.

Biophysical journal·2026
Same author

Evaluation of 3 commercial assays for the measurement of tissue factor activity in human plasma.

Research and practice in thrombosis and haemostasis·2026
Same author

Mechanisms of thrombin inhibition by protein S and the TFPIα-fVshort-protein S complex.

ArXiv·2025
Same author

The kinetics and interplay of thrombin inhibition by 4 plasma proteinase inhibitors.

Blood vessels, thrombosis & hemostasis·2025
Same author

Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse model.

Blood advances·2025
Same journal

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports·2006
Same journal

The treatment of immune thrombocytopenic purpura in children.

Current hematology reports·2006
Same journal

Volume-reduced platelet concentrates.

Current hematology reports·2006
Same journal

Platelet transfusions in infants with necrotizing enterocolitis.

Current hematology reports·2006
Same journal

Methods for counting platelets in severe thrombocytopenia.

Current hematology reports·2006
Same journal

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Current hematology reports·2006
See all related articles

The traditional coagulation cascade model has limitations. Modern hemostasis research emphasizes cellular control and host factors for a more accurate understanding of blood clotting in vivo.

Area of Science:

  • Biochemistry
  • Hematology
  • Physiology

Background:

  • The coagulation cascade, a series of proteolytic reactions, was a breakthrough in understanding biologic amplification.
  • The extrinsic, intrinsic, and common pathways model explains protein interactions and guides coagulation tests.

Purpose of the Study:

  • To discuss the limitations of the coagulation cascade model for in vivo hemostasis.
  • To present the evolution of hemostasis understanding towards a cell-centric view.
  • To highlight non-coagulation factors influencing hemostasis.

Main Methods:

  • Review of historical and modern hemostasis concepts.
  • Analysis of the limitations of the "cascade" model.
  • Emphasis on cellular and host factor roles in coagulation.

Related Experiment Videos

Main Results:

  • The "cascade" model, while foundational, is insufficient for explaining in vivo hemostasis.
  • Current understanding highlights the critical role of cells in regulating coagulation.
  • Non-coagulation host factors significantly impact hemostatic effectiveness.

Conclusions:

  • Hemostasis is a complex process better understood through a cell-based model.
  • Cellular interactions and host factors are crucial for effective blood clot formation.
  • The evolution of hemostasis models reflects a deeper understanding of in vivo physiology.